FDA approves CTI BioPharma's bone marrow cancer drug
(Reuters) - CTI BioPharma Corp said on Monday the U.S. Food and Drug Administration approved its drug Vonjo (pacritinib) for treating adult patients w...
Source: wtbx.com
Page 14 - Pharma Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Corp Today - Breaking & Trending Today
Ramm Pharma Announces Cease Trade Order
TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”). On February 22, 2022, the Company announced that, for reasons...
Source: globenewswire.com
CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the...
Source: prnewswire.com
CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the...
Source: prnewswire.com
Ramm Pharma Announces Cease Trade Order
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com